[HTML][HTML] Biosurfactants' potential role in combating COVID-19 and similar future microbial threats

PA Çelik, EB Manga, A Çabuk, IM Banat - Applied Sciences, 2020 - mdpi.com
During 2020, the world has experienced extreme vulnerability in the face of a disease
outbreak. The coronavirus disease 2019 (COVID-19) pandemic discovered in China and …

Photoactive lanthanide‐based upconverting nanoclusters for antimicrobial applications

N Kandoth, S Barman, A Chatterjee… - Advanced Functional …, 2021 - Wiley Online Library
Developing photoactive nanosystems against microbial infection and its therapeutic
application is compromised by the lack of suitable materials or molecular dyes activatable at …

[HTML][HTML] Solid lipid nanoparticles, an effective carrier for classical antifungal drugs

S Almawash - Saudi Pharmaceutical Journal, 2023 - Elsevier
Solid-lipid nanoparticles (SLNs) are an innovative group of nanosystems used to deliver
medicine to their respective targets with better efficiency and bioavailability in contrast to …

[HTML][HTML] The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants

K Kumari, A Nandi, A Sinha, A Ghosh… - Journal of Infection and …, 2023 - Elsevier
The recent emergence and outbreak of the COVID-19 pandemic confirmed the
incompetence of countries across the world to deal with a global public health emergency …

[HTML][HTML] Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections

M Barani, M Mukhtar, A Rahdar, G Sargazi… - Molecules, 2021 - mdpi.com
The blood–brain barrier (BBB) is the protective sheath around the brain that protects the
sensitive microenvironments of the brain. However, certain pathogens, viruses, and bacteria …

[HTML][HTML] COVID-19-associated mucormycosis and treatments

V Subramaniyan, S Fuloria, HK Darnal… - Asian Pacific Journal …, 2021 - journals.lww.com
In the current pandemic, COVID-19 patients with predisposing factors are at an increased
risk of mucormycosis, an uncommon angioinvasive infection that is caused by fungi with …

Harnessing the immune response to fungal pathogens for vaccine development

A Rivera, J Lodge, C Xue - Annual review of microbiology, 2022 - annualreviews.org
Invasive fungal infections are emerging diseases that kill over 1.5 million people per year
worldwide. With the increase of immunocompromised populations, the incidence of invasive …

The use of nanoparticles as alternative therapeutic agents against Candida infections: an up-to-date overview and future perspectives

IE Mba, EI Nweze - World Journal of Microbiology and Biotechnology, 2020 - Springer
Candida spp. are opportunistic fungi that can cause severe infections especially in
immunocompromised patients. Candidiasis is currently the most frequent fungal disease …

[HTML][HTML] Design of a lipid nano-delivery system containing recombinant Candida albicans chitinase 3 as a potential vaccine against fungal infections

A Costa-Barbosa, MI Pacheco, C Carneiro… - Biomedicine & …, 2023 - Elsevier
Opportunistic fungi cause lethal systemic infections and impose high medical costs to health
systems. The World Health Organization has recognized the importance of fungal infections …

Plausible Mechanistic Insights in Biofilm Eradication Potential against Candida spp. Using In Situ-Synthesized Tyrosol-Functionalized Chitosan Gold Nanoparticles …

TC Yadav, P Gupta, S Saini, S Mohiyuddin, V Pruthi… - ACS …, 2022 - ACS Publications
In the present study, tyrosol-functionalized chitosan gold nanoparticles (Chi-TY-AuNPs)
were prepared as an alternative treatment strategy to combat fungal infections. Various …